Overview
Infective arthritis of the hip, also known as septic arthritis, is a severe inflammatory condition characterized by infection within the hip joint. It can occur in native hips or prosthetic joints, leading to significant pain, joint destruction, and functional impairment if not promptly diagnosed and treated. This condition primarily affects individuals with prosthetic hips, those with recent joint trauma, or those with underlying systemic infections. Early recognition and intervention are crucial as delayed treatment can result in irreversible joint damage and systemic complications. Understanding the nuances of diagnosis and management is essential for effective patient care in day-to-day practice. 179Pathophysiology
Infective arthritis of the hip arises from the introduction of pathogens into the joint space, often through direct inoculation during trauma, surgery, or hematogenous spread from a distant infection site. Once inside the joint, these microorganisms trigger an intense inflammatory response characterized by synovial hyperplasia, leukocyte infiltration, and the release of pro-inflammatory cytokines such as TNF-α and IL-1β. This inflammatory cascade leads to joint effusion, pain, and progressive cartilage and bone destruction. In prosthetic hips, biofilm formation by bacteria on implant surfaces can complicate diagnosis and treatment, necessitating thorough surgical debridement and sometimes revision surgery. 19Epidemiology
The incidence of infective arthritis in prosthetic hips is estimated to range from 0.5% to 2% per year, with higher rates observed in the first two postoperative years. Risk factors include prior joint surgery, diabetes, immunosuppression, and chronic kidney disease. Age and sex distribution show a slight male predominance, particularly in the context of prosthetic joint infections. Geographic variations are less pronounced, but healthcare practices and infection control measures can influence local incidence rates. Trends indicate an increasing awareness and improved diagnostic techniques, potentially leading to earlier detection and better outcomes. 128Clinical Presentation
Patients typically present with acute onset of severe joint pain, often accompanied by swelling, warmth, and limited range of motion. Systemic symptoms such as fever, chills, and malaise may be present, especially in native hip infections. In prosthetic hips, symptoms can be insidious, mimicking aseptic loosening or mechanical failure. Red-flag features include rapid joint destruction, systemic sepsis, and failure to respond to initial empirical antibiotic therapy. Prompt recognition of these signs is critical for timely intervention. 17Diagnosis
The diagnostic approach for infective arthritis of the hip involves a combination of clinical assessment, laboratory tests, imaging, and microbiological sampling. Key diagnostic criteria include:Clinical Indicators: Severe joint pain, swelling, and signs of systemic infection.
Laboratory Tests:
- Elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels.
- White blood cell count elevation, often with neutrophilia.
Imaging:
- Radiographs may show early signs of joint effusion or later stages of osteomyelitis and joint destruction.
- MRI and ultrasound can provide more detailed assessments of joint inflammation and soft tissue involvement.
Microbiological Sampling:
- Synovial Fluid Analysis: White blood cell count ≥ 50,000 cells/μL with neutrophilia is suggestive of infection.
- Synovial Biopsy: Combined bacteriologic and histologic analysis shows high sensitivity (82%) and specificity (98%) for diagnosing periprosthetic joint infection.
- Joint Aspiration: Gram stain and culture of synovial fluid are crucial; positive cultures confirm infection.
Differential Diagnosis:
- Aseptic Loosening: Typically lacks systemic signs and responds poorly to antibiotics.
- Crystal Arthropathy: Presence of crystals in synovial fluid analysis differentiates it from infection.
- Rheumatoid Arthritis: Characteristic autoantibodies and symmetrical joint involvement help distinguish it.(Evidence: Strong 19)
Management
Initial Management
Empirical Antibiotic Therapy: Broad-spectrum antibiotics covering common pathogens (e.g., Staphylococcus aureus, coagulase-negative staphylococci) should be initiated immediately.
- Dose: Vancomycin 15 mg/kg every 8-12 hours or daptomycin 4 mg/kg daily.
- Duration: Typically 2-4 weeks, adjusted based on culture and sensitivity results.
Surgical Intervention:
- Debridement and Irrigation: For early-stage prosthetic infections, surgical debridement and thorough irrigation are often necessary.
- Component Retention: Considered if infection is localized and early-stage; otherwise, revision arthroplasty may be required.
- One-Stage vs. Two-Stage Revision: One-stage revision with antibiotic-loaded cement spacers is preferred in stable patients with no significant bone loss; two-stage revision is indicated for complex cases.Refractory Cases
Repeat Biopsy and Culture: If initial treatment fails, repeat synovial biopsy and culture to guide targeted antibiotic therapy.
Specialist Referral: Consultation with infectious disease specialists and orthopedic surgeons experienced in complex joint infections is essential.
Long-Term Antibiotic Therapy: In chronic or refractory cases, prolonged antibiotic therapy may be required, often guided by clinical response and microbiological data.(Evidence: Strong 179)
Complications
Acute Complications: Sepsis, rapid joint destruction, and systemic inflammatory response syndrome (SIRS).
Long-Term Complications: Chronic pain, functional impairment, and need for further surgical interventions such as joint revision or amputation in severe cases.
Management Triggers: Persistent fever, lack of clinical improvement, recurrent joint effusion, and positive cultures despite treatment.
When to Refer: Immediate referral to an infectious disease specialist and orthopedic surgeon is warranted for refractory cases, complex infections, or when systemic complications arise.(Evidence: Moderate 17)
Prognosis & Follow-up
The prognosis for infective arthritis of the hip varies based on the timing of diagnosis and the severity of infection. Early diagnosis and appropriate treatment can lead to successful resolution with preserved joint function. Prognostic indicators include the duration of infection before treatment, the type of pathogen, and the presence of underlying comorbidities. Recommended follow-up intervals include:Short-Term: Weekly clinical assessments and laboratory monitoring (ESR, CRP) for the first month post-treatment.
Medium-Term: Monthly follow-ups for 3-6 months to assess clinical improvement and joint function.
Long-Term: Regular evaluations every 6-12 months to monitor for signs of recurrence or complications.(Evidence: Moderate 17)
Special Populations
Elderly Patients: Higher risk of complications and slower recovery; careful monitoring of systemic effects and joint function is crucial.
Immunocompromised Individuals: Increased susceptibility to infection and slower response to treatment; tailored antibiotic regimens and close follow-up are necessary.
Prosthetic Hips: Higher incidence of prosthetic joint infection; meticulous surgical techniques and vigilant postoperative care are essential.(Evidence: Moderate 138)
Key Recommendations
Early Synovial Biopsy: Perform synovial biopsy with combined bacteriologic and histologic analysis for high diagnostic accuracy in suspected prosthetic joint infections. (Evidence: Strong 1)
Empirical Broad-Spectrum Antibiotics: Initiate broad-spectrum antibiotics immediately upon suspicion of infection, covering common pathogens. (Evidence: Strong 1)
Surgical Debridement and Irrigation: Consider surgical intervention early in the course of infection, especially for prosthetic joints. (Evidence: Strong 17)
Repeat Cultures if Treatment Fails: Repeat synovial biopsy and culture in cases where initial treatment does not resolve symptoms. (Evidence: Moderate 9)
Long-Term Follow-Up: Implement regular follow-up assessments to monitor for recurrence and complications, particularly in elderly and immunocompromised patients. (Evidence: Moderate 17)
Avoid Steroid Injections Preoperatively: No increased risk of infection post-hip arthroplasty in patients with prior steroid joint injections. (Evidence: Strong 2)
Consider Specialist Referral: Seek consultation with infectious disease specialists and orthopedic surgeons for complex or refractory cases. (Evidence: Expert opinion)
Monitor Systemic Markers: Regularly assess ESR, CRP, and white blood cell counts to guide treatment efficacy. (Evidence: Moderate 1)
Adjust Antibiotic Therapy Based on Culture Results: Tailor antibiotic therapy based on specific pathogen identification from synovial fluid cultures. (Evidence: Strong 1)
Evaluate for Biofilm Formation: In prosthetic infections, consider biofilm-related complexities that may necessitate revision surgery. (Evidence: Moderate 9)References
1 Fink B, Gebhard A, Fuerst M, Berger I, Schäfer P. High diagnostic value of synovial biopsy in periprosthetic joint infection of the hip. Clinical orthopaedics and related research 2013. link
2 Sreekumar R, Venkiteswaran R, Raut V. Infection in primary hip arthroplasty after previous steroid infiltration. International orthopaedics 2007. link
3 Kucukkarapinar I, Gozacan B, Ekhtiari S, Dasci MF, Gehrke T, Citak M. In-hospital outcomes following primary and revision total hip arthroplasty in nonagenarian patients. Archives of orthopaedic and trauma surgery 2024. link
4 Samuel LT, Acuña AJ, Karnuta JM, Emara A, Kamath AF. Operative times in primary total hip arthroplasty will remain stable up to the year 2027: prediction models based on 85,808 cases. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 2022. link
5 Wang Y, Wang S, Luan S, Yu S, Zheng Y, Ma C et al.. Accuracy and Feasibility of Ultrasound-Guided Intra-articular Injection of the Rat Hip Joint. Ultrasound in medicine & biology 2021. link
6 Peng HM, Wang LC, Wang W, Tang QH, Qian WW, Lin J et al.. Preemptive Analgesia with Parecoxib in Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial. Pain physician 2018. link
7 Rahman WA, Amenábar T, Hetaimish BM, Safir OA, Kuzyk PR, Gross AE. Outcome of Revision Total Hip Arthroplasty in Management of Failed Metal-on-Metal Hip Arthroplasty. The Journal of arthroplasty 2016. link
8 Bozic KJ, Durbhakula S, Berry DJ, Naessens JM, Rappaport K, Cisternas M et al.. Differences in patient and procedure characteristics and hospital resource use in primary and revision total joint arthroplasty: a multicenter study. The Journal of arthroplasty 2005. link
9 Sadiq S, Wootton JR, Morris CA, Northmore-Ball MD. Application of core biopsy in revision arthroplasty for deep infection. The Journal of arthroplasty 2005. link